This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Yes indeed GF I spoke to both of them for about 10 mins after the meeting..I wasnt going to go but I forced myself and I'm glad I did now.Anyhow the impression I get from them is they are disappointed that the market has not picked up on the potential of Oncosense and its potentially billion pound market..I'm holding for the short term and when they finally announce the start of clinical trials may indeed buy more..

Yup Mitzy I expect a very positive update by Mike Walters in the next 24 hours, he also feels the market as not got its head around just how big the developments are at MMG.

cheers GF.

DB informed me that they intend to finalise trials by the end of Spring 2005...n other words in about 6 months time.. they have at least 6 if not 12 compounds that are showing promise..more later..

Cheers Mitzy, as usual much appreciated.

cheers GF.

Very quiet since the Agm last month but we should have some further news mid Dec so I understand..meanwhile DB doing his rounds again this week in the City.

Glad of that Mitzy Im still in and have added since we last spoke.

cheers GF.

Bit of a fall back today due to lack of news but dont worry as there should be a RNS next Thursday when David Best gets back in the office..if it is good news on R it will stop falling and start rising.

Hope you're right Mitzy.

If that is the case though, why are people selling. Bad News?
Better not do an Antisoma or I will be pissed off having got more in Sept.

Stay cool andy.

cheers GF.

Killik in fact last week said that theres should be some very positive news out very soon. Wish id remembered to post it now. They dont have an archives file.

cheers GF.

News out hopefully this week say Thursday or Friday so its a question of wait and see..cheers.

Thanks Mitzy for keeping us informed.

cheers GF.

well the news was a day late for which I apologise..but the news was great all the same although the time scale has upset some people by all accounts..but as DB has said 2005 should be an excellent year so heres hoping.

Yup some great news in there with the report.

cheers GF.

Mitzy, do you still believe 4 by end of 2005?
I cannot understand why this is languishing around 60p if the potential for 2005 is so great, what is going on? I don't suppose the institituions who stumped up cash at 70pence per share are too impressed at the moment either.
When will we get the good news that drives this further?

Technically chart is very weak, last break up from 58p found resistance at the 200 ema at 62p.One rule of thumb is to never buy a stock while its trading below its long term average. Long term mmg could be a huge, however short term until with have some further news on trials etc , SP imo will be driven technically which unfortunately at present will be to continue with the downtrend.

Guy's, I have posted here before as a long, long term medical marketing holder....... I held it when it was 'bioscience innovation' listed on ofex.
I have topped up since but am becoming increasingly frustrated at the illogical swings. It does shadow the ftse but with greater swings. In my opinion the only real potential for this share to go big is a takeover.
I think that due to the structure of the company it is slightly too 'vague' for the big institutions to take any great holdings, however if one of the big bio's takes a shine to one of the incubated lines I think a takeover could be on the cards.
I know there are potentialy explosive products in the pipieline, but that has been the case for some years and I have not retired on this one yet!!!
I am still bullish and will hold but not as in love as before

good luck
rob

We should recieve news on the start of Ruthenium trials within the next 2 weeks which is the news we have been waiting for.I agree that short term the sp is looking weak but as soon as we have the start of the trials date we should see some support...400p is still possible if the trials are fast tracked within 12 months .

Old news but worth posting again.

http://www.diamondtalk.com/forums/showthread.php?postid=365355#post365355